Top quality manufactured locally: SCHOTT well prepared for growth of Indonesian pharmaceutical market

Allpack 2012: SCHOTT Pharmaceutical Packaging presents itself as the leading supplier to Southeast AsiaMainz/Jakarta, November 16, 2012 – SCHOTT Pharmaceutical Packaging will be presenting itself as one of the leading suppliers of high-quality pharmaceutical primary packaging in Asia at Allpack in Jakarta, Indonesia.

From November 21 – 24, 2012, the main focus at the SCHOTT booth BK 030 in hall B will be on the company’s wide range of ampoules and vials. In addition, the international technology group will also be presenting innovative versions of its cartridges and prefillable syringes.

SCHOTT expects to see Indonesia’s pharmaceutical market continue to grow, mainly as a result of political initiatives. “Demand for better medical care will rise when state-funded social security systems are introduced for 240 million people in 2014. At the same time, the demands are getting higher and higher for pharmaceutical companies and manufacturers of primary packaging,” says Gunawan Setokusumo, Regional Sales Director for Asia, and adds, “Today, SCHOTT already manufactures pharmaceutical primary packaging in close cooperation with its customers and in the highest quality. In this way, we are helping our customers to reap long-term benefits from market growth in Indonesia.”

SCHOTT has been manufacturing ampoules, vials and pipettes for the pharmaceutical industry in Indonesia already for 15 years. With an annual capacity of 850 million units, SCHOTT Igar Glass in Bekasi operates the largest plant for pharmaceutical primary packaging in Southeast Asia. Furthermore, the plant in Bekasi strictly follows the “Good Manufacturing Practice” (GMP) guidelines and has been certified based on all of the relevant ISO standards.

The SCHOTT product highlights at Allpack 2012

With Type I plus®, SCHOTT introduced a set of delamination resistant vials for the first time ever. SCHOTT Type I plus® vials are particularly well-suited for pharmaceutical products that are incapable of being stored in conventional Type I glass. These include biopharmaceutical proteins, for example, which tend to show denaturation or formulations that interact with their containers. SCHOTT Type I plus® features a coating on the inside that is covalently bonded with the glass matrix and drastically reduces interactions between the glass surface and the respective medication. This translates into greater security and higher stability for medications. The vials with their outstanding barrier properties can be subjected to all types of normal pharmaceutical procedures, including washing, autoclaving, sterilization or depyrogenation.

600450 Top quality manufactured locally: SCHOTT well prepared for growth of Indonesian pharmaceutical market
Date: 21 November 2012

See more news about:

Others also read

The Emirates Arena and Sir Chris Hoy Velodrome have just been completed, creating a new world class sporting landmark for Scotland.
Hawaii and Texas Top List of 20 States and D.C. Adding Construction Jobs Since November 2011 as Delaware and New York Trail; Vermont and Louisiana Led 19 States with One-Month Gain, D.
The EBRD is providing loans worth €110 million to Turkish glass manufacturer Trakya Cam A.Ş. that will expand its product range at home and in Bulgaria and also establish a presence on the Russian market, setting new standards in energy efficiency.
The United States is honoring its role, to the best of its ability, as the world's locomotive, although despite the positive performance of the real estate market, America seems to be recovering slower than expected.
We sincerely thank all our members, friends and visitors for being part of GlassOnWeb and its success during 2012.
SAGE Electrochromics, Inc., a world leader in the development and manufacture of dynamic glass, located in Faribault, Minn., today announced it has filed a lawsuit in U.S.

Add new comment